AAM All Access Podcast - Dan Leonard speaks with Mary Beth Powers, President and CEO of CMMB.
Learn More
Close

Resources

Find up-to-date information on generics and biosimilars
Filter Resources
Video
Dec 2, 2022 | Erica Klinger
Back Together: GRx+Biosims 2022 Conference Recap
Video
Nov 30, 2022 | Erica Klinger
Desi is Back Playing Soccer and Doing "Normal Kid" Stuff
Video
Nov 28, 2022 | Erica Klinger
AAM's Erica Klinger speaks with Connor Nell and Brian Biehn from AmerisourceBergen #GBW2022
GRx+Biosims 2022 attendees
Blog
Nov 23, 2022 | Erica Klinger
Back Together: GRx+Biosims 2022 Conference Recap
Video
Nov 16, 2022 | Erica Klinger
Patient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeek
IGBA Global Biosimilars Week: Strengthening Healthcare – The Value of Biosimilar Medicines. November 11-18, 2022.
Press Release
Nov 14, 2022 | Susan Reilly
Raising Awareness for Biosimilars for Stakeholders Around the World
Medicare
Blog
Oct 19, 2022 | Monét Stanford
Patients Pay More When Generic Drugs Are Placed On Non-Generic Tiers, Even Though Prices For Generics Are Going Down
Meitheal Manufacturer
Blog
Oct 14, 2022 | Jewel Smith
Members Spotlight: Meitheal Pharmaceuticals
Video
Oct 14, 2022 | Erica Klinger
Join Us at Access! 2023
Closeup cashless wireless payment with credit card at the pharmacy
Press Release
Oct 14, 2022 | Susan Reilly
AAM Statement on President Biden's Executive Order on Lowering Prescription Drug Costs
A young businesswoman delivering a speech during a conference
Fact Sheet
Oct 13, 2022 | Erica Klinger
How to Talk to Voters About the High Cost of Medicines and Ways to Lower Them
""
Press Release
Oct 3, 2022 | Susan Reilly
AAM Statement on the Centers for Medicare & Medicaid Services’ Implementation of Medicare Part B Payment Changes for Biosimilars

Association for Accessible Medicines

601 New Jersey Ave NW, Suite 850
Washington DC 20001

 

202.249.7100
info@accessiblemeds.org

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.